Skip to navigation Skip to content Skip to footer

News

News

We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees

Image from Record early stage funding for Oxford projects News Article

Record early stage funding for Oxford projects

31st March 2016

All News | Financial News | Spinouts & Startups | Startup Incubator

Thirty-five Oxford projects received £4.6m in funding from proof-of-concept and seed funds managed by Oxford University Innovation in the last financial year.

Image from Spinout OrganOx completes European clinical trial News Article

Spinout OrganOx completes European clinical trial

21st March 2016

All News | Spinouts & Startups

Organox has completed the European multi-center trial of its Organox metra device, which improves the success of liver transplantation.

Image from Machine learning spinout from Oxford University unlocks big data insights News Article

Machine learning spinout from Oxford University unlocks big data insights

16th February 2016

All News | Spinouts & Startups

Image from Oxford spinout Zegami launches data discovery software to manage “information tsunami” News Article

Oxford spinout Zegami launches data discovery software to manage “information tsunami”

9th February 2016

All News | Spinouts & Startups

Image from Oxford spin-out Orbit Discovery launches peptide-discovery platform News Article

Oxford spin-out Orbit Discovery launches peptide-discovery platform

25th January 2016

All News | Spinouts & Startups

Oxford Endovascular inventor Professor Zhong You, Chairman Brian Howlett and CEO Mike Karim

Oxford develops tiny mesh tube devices to treat brain aneurysms

6th January 2016

All News | Spinouts & Startups

An Oxford spin-out is developing advanced tiny metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms.

Image from Spinout Celleron Therapeutics announces encouraging clinical results with cancer drug News Article

Spinout Celleron Therapeutics announces encouraging clinical results with cancer drug

3rd December 2015

All News | Spinouts & Startups | Technology News

Celleron Therapeutics is developing personalised medicine for cancer patients. The company has announced results from its first human trial in patients at Oxford’s Churchill Hospital with advanced treatment-resistant aggressive cancer.

Image from Summit hits first milestone in Duchenne muscular dystrophy program News Article

Summit hits first milestone in Duchenne muscular dystrophy program

2nd December 2015

All News | Spinouts & Startups | Technology News

Nasdaq-listed Oxford spinout Summit Therapeutics has hit its first research milestone as part of a multiyear strategic alliance with the University of Oxford. The collaboration is focussed on developing future-generation utrophin modulators for the potential treatment of all patients with the progressive muscle wasting disorder Duchenne Muscular Dystrophy.

Image from Extension of strategic alliance with Summit News Article

Extension of strategic alliance with Summit

17th November 2015

All News | Spinouts & Startups | Technology News

Summit Therapeutics and Oxford have announced a multi-year extension of their strategic alliance for the development of utrophin modulators to treat Duchenne Muscular Dystrophy.

Image from Spinout Perspectum secures FDA clearance, closes $5m round News Article

Spinout Perspectum secures FDA clearance, closes $5m round

12th November 2015

All News | Spinouts & Startups | Technology News

Perspectum announced today it has been given US FDA clearance to market its test for diagnosing and measuring liver disease.

Prev
1
…
15
16
17
18
19
…
34
Next

Sparks Background Image

Ready to get in touch?

Contact Us

Sparks Background Image

© Oxford University Innovation